Provectus Biopharmaceuticals Inc. To Celebrate NYSE MKT Listing With Opening Bell Ceremony

Published: May 19, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Biopharmaceuticals, Inc. (PVCT) (, a development-stage oncology and dermatology biopharmaceutical company (“Provectus” or the “Company”), announced today that its CEO and Chairman Dr. Craig Dees, PhD, its CTO Dr. Eric Wachter, PhD and its CFO and COO Peter Culpepper, along with Alfred E. Smith, IV, Lead Independent Director of its Board, along with key advisors will ring The Opening Bell® at the New York Stock Exchange at 9:30 a.m. EDT on Thursday, May 22, 2014.

Help employers find you! Check out all the jobs and post your resume.

Back to news